Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.
about
Ethnic background and genetic variation in the evaluation of cancer risk: a systematic reviewOvarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionVariants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory.Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersUnderstanding of BRCA VUS genetic results by breast cancer specialists.Differences in BRCA counseling and testing practices based on ordering provider type.Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesGenetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.Attitudes and practices among internists concerning genetic testingPrimary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.A Case for Inclusion of Genetic Counselors in Cardiac CareUtilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study.A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to considerAge at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients.Development, Implementation, and Assessment of a Genetics Curriculum Across Institutions.How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age.Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States.Next-generation sequencing in the clinic: are we ready?The evolution of personalized cancer genetic counseling in the era of personalized medicine.An assessment of time involved in pre-test case review and counseling for a whole genome sequencing clinical research programAttitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing.Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.Classification and Clinical Management of Variants of Uncertain Significance in High Penetrance Cancer Predisposition Genes.Electronic health record interventions at the point of care improve documentation of care processes and decrease orders for genetic tests commonly ordered by nongeneticists.Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.Delivery of clinical genetic consultative services in the Veterans Health Administration.Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.Comprehensive functional assessment of MLH1 variants of unknown significance.Enhancing exposure to genetics and genomics through an innovative medical school curriculum.Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals.Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
P2860
Q24288685-F4B9F996-833F-4B36-83D7-B2385F2F7A58Q26744525-8BA8B523-9083-40ED-B05B-DDC9F1E57C1DQ30487580-F8369907-E6AF-4664-A4BE-46757D1AA01DQ34022144-88C1F4AF-A004-4DC1-9CB8-3F1DB651183DQ34475484-046ADFED-8EB8-4DC0-A613-BD2067FD31F8Q34503138-29C88764-2711-43F2-8E02-3A9A0C076758Q34691719-92554F9C-CA05-4AEE-BE56-1FF54B00111EQ35146870-2AB92D8F-99D3-452F-8443-B0B22986E75AQ35163789-A2A19D70-6FA4-4D82-92BB-DE4AFD372F40Q35618857-B2D557C1-7A21-4166-8844-A14239F55E50Q35909002-9451B844-3A3E-4D07-B539-B9600CF1E904Q36208056-A67F22B1-8A1D-43C5-972D-28FBBD195D69Q36229139-A6ED6A5A-0B8A-48AC-B588-4E12E3032769Q36470860-9C70E39F-DF45-44B7-805A-DFBC1688234DQ36582758-12AD753A-98D2-4B66-911A-A1C7E81DF722Q36789430-792214C0-C267-426B-A29D-A8D854A7E6CBQ36884609-3DC7DBE9-6E88-424E-B9A6-B91E5AC3A4ADQ37237966-397E4B44-373F-4111-B5F0-626F1E9059D1Q37395977-5B3B7BD5-D87D-425F-B302-DF9D85DFB101Q37427226-72D00E2F-4643-4DEE-A1F8-F6A0EC8E146BQ37450153-B2B855B8-20B9-4DB1-93A5-E27BE4C23042Q37478694-0F92D102-7A0F-4C73-8FC4-8F9CD21C37F7Q37528319-9160ADC0-D4A4-4CB9-A231-1DED3637A3F5Q38191457-C11224D4-E6FE-401B-BE1B-20FF06CC33CCQ38449983-0639DA4F-EA2F-4B2D-AD9F-A12EF3FA6EC2Q38634883-29D73FA1-1EF5-4F9F-835B-48C71BC61983Q38700025-1B1DDB66-3389-45CB-A51C-0202D0E0CC3BQ38881922-AEFB65FF-BBE5-467E-B73D-F4B5DBC0FE7CQ40174495-00DCE23C-3AE6-4B8F-A8C8-11CF5EE2C33CQ44015501-2ADA1460-DB2D-4CAA-8A13-94461741520AQ45937929-4F54078A-7133-4211-960E-4DF5F5CFD250Q46109910-94EBD7C0-56C9-4926-87D4-B89878B82880Q46739746-53E35299-3447-462E-9DC8-8131BA451EDBQ47449157-7D5A82FD-FB4B-431F-9EC6-E3B422EBC9F6Q50976587-658CC45F-93C6-4DD6-942B-7A27951E6AD2Q54489362-985FB7AA-3437-4D30-8718-B07A4AC2C81DQ55219319-A64C7AEE-A3DB-421D-A74B-6E37BA97E6CAQ55458851-C9D1248B-348B-44A5-A800-CAEF7B0744A3
P2860
Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@ast
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@en
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@nl
type
label
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@ast
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@en
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@nl
prefLabel
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@ast
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@en
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@nl
P2093
P2860
P1433
P1476
Genetic testing and cancer ris ...... sicians for at-risk relatives.
@en
P2093
Armin D Weinberg
Bethany Parks
H Paul Cooper
P Adam Kelly
Sharon E Plon
Shweta U Dhar
Stephanie Staggs
Susan Hilsenbeck
P2860
P2888
P304
P356
10.1097/GIM.0B013E318207F564
P407
P577
2011-02-01T00:00:00Z
P6179
1031827667